In the BioHarmony Drug Report Database
Hexaminolevulinate
Cysview (hexaminolevulinate) is a small molecule pharmaceutical. Hexaminolevulinate was first approved as Cysview on 2010-05-28. Cysview’s patent is valid until 2036-12-19 (FDA).
Trade Name
|
Cysview |
|---|---|
Common Name
|
hexaminolevulinate |
ChEMBL ID
|
CHEMBL1201784 |
Indication
|
|
Drug Class
|
Image (chem structure or protein)